Michael Davin

Michael is Chairman of the Board at Inkbit. Prior to Inkbit, Michael served as CEO at Cynosure, a manufacturer of medical lasers. During his 14-year tenure at Cynosure, he led the company to an IPO, oversaw its international expansion, executed key acquisitions and achieved compound annual revenue growth of more than 20 percent. Cynosure was acquired by Hologic in 2017 for $1.7 billion. Michael received his BS and BA from Southern New Hampshire University.